Ayumu Arakawa

8PUBLICATIONS
30CO-AUTHORS
Molecular targetsChemotherapyPredictive and prognostic markersAdolescent healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 15, 2026
Preclinical Evaluation of Liposomal Eribulin (E7389-LF) in a Panel of Sarcoma Patient-Derived Xenograft Models.

|Apr 11, 2026
Safety and Efficacy of Vinorelbine and Continuous Low-Dose Cyclophosphamide Chemotherapy in Japanese Pediatric Patients With Relapsed or Refractory Rhabdomyosarcoma.

Risa Yanai, Minako Sugiyama, Bunpei Miyazaki

|Mar 15, 2026
Analysis of the Relationship Between Survival and Postoperative Infection in Patients With Osteosarcoma.

Satoshi Kamio, Koichi Ogura, Kenji Sato

|Sep 09, 2025
Pediatric Alpha-Fetoprotein-Producing Gastric Cancer Presenting With Dysphagia and Multiple Liver Tumors.

Takayuki Hirano, Reina Hoshi, Bin Yamaoka

|Mar 17, 2025
Successful Multidisciplinary Treatment of Tracheal Lymphoepithelial Carcinoma in an Adolescent Patient.

Ayumu Arakawa, Minako Sugiyama, Eriko Uchida

|Jul 31, 2024
MGMT protein expression is a reliable predictive biomarker for temozolomide-containing chemotherapy in osteosarcoma.

Yoshinori Uchihara, Katsutsugu Umeda, Yosuke Yamada

Pageof 2

Frequent Collaborators

1 joint publications

Takashi Kohno

1 joint publications

Hisaki Aiba

1 joint publications

Shu Yazaki

1 joint publications

Eisuke Kobayashi